My broker says shorts are up a bit from ~1% to 2% over the last month but not that significant overall. Statement provided reads pretty much as expected at this stage of the life cycle. As are the personnel appointments. As others have said it is puzzling why the SP has run down but nothing fundamental seems to have changed except the macro trend of money flowing out of growth especially spec growth resources.
A stock like this is always going to be a bumpy ride so I took it as a buying op myself. But WTFK's...
- Forums
- ASX - By Stock
- HAS
- Ann: Yangibana Project Update
Ann: Yangibana Project Update, page-20
Featured News
Add HAS (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.53M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1755 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 1006 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.280 |
3 | 61000 | 0.270 |
1 | 4000 | 0.265 |
6 | 232100 | 0.260 |
1 | 11768 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 1006 | 2 |
0.285 | 15892 | 5 |
0.295 | 35000 | 1 |
0.300 | 10000 | 1 |
0.310 | 198209 | 3 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
HAS (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online